A law on the MASIMO files on the “designed” oxygen monitoring feature from Apple

Massimo, the Medical Technology Company that led a lawsuit that led to temporary sales of the Apple Watch Series 9 and Ultra 2 series, prosecution After days of customs and US border protection after Apple It released it The feature of monitoring blood oxygen. This is just the last update in the long legal epic between Massimo and Apple, which started when the former filed a lawsuit against iPhonemaker in 2021, accused of violating many patents of light blood oxygen. After the court Side with Massimo In 2023, it was Apple Forced to stop selling Series 9 and Ultra 2 in the United States for a few weeks.

In order to circumvent the import ban, Apples were removed Apply blood oxygen to the monitoring forms sold in the United States. Just a few days ago, the company foot “Designed Blood Oxtures feature” for Watch Series 9, Series 10 and Watch Ultra 2 models. The feature works by measuring and calculating data from watch sensors on the associated iPhone devices instead. Users will then be able to display blood oxygen data in the respiratory system in the health app.

Apple said the update “was enabled by a modern American customs rule.” But Massimo said in her complaint (cross Bloomberg LawHe only heard about the ruling, which was submitted on August 1, when Apple issued the advertisement. He argued that the agency usually requires hearing both sides before making such decisions and that customs “exceeded its authority.” Massimo is now asking the court to establish a judicial order regarding UCBP decision, and in the end, to allow only imports of devices if the function of tracking oxygen in the blood is disabled.

“Every day it passes that this illegal ruling remains in force, Massimo is in an unorganized way of its right to be free from unfair commercial practices and maintain its competitive position in the American market,” said Massimo.